ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IQV IQVIA Holdings Inc

213.96
-3.50 (-1.61%)
After Hours
Last Updated: 16:56:12
Delayed by 15 minutes

Period:

Draw Mode:

Volume 904,371
Bid Price
Ask Price
News -
Day High 217.91

Low
167.42

52 Week Range

High
261.73

Day Low 212.97
Company Name Stock Ticker Symbol Market Type
IQVIA Holdings Inc IQV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-3.50 -1.61% 213.96 16:56:12
Open Price Low Price High Price Close Price Prev Close
216.24 212.97 217.91 213.96 217.46
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,809 904,371 $ 214.21 $ 193,724,335 - 167.42 - 261.73
Last Trade Time Type Quantity Stock Price Currency
16:10:00 146,970 $ 213.96 USD

IQVIA Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
38.81B 181.50M - 14.98B 1.36B 7.48 28.58
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

IQVIA News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IQV Message Board. Create One! See More Posts on IQV Message Board See More Message Board Posts

Historical IQV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week220.29221.12212.52217.451,392,879-6.33-2.87%
1 Month233.07236.72212.34221.941,263,343-19.11-8.20%
3 Months254.13256.29212.34230.26974,500-40.17-15.81%
6 Months217.90261.73205.38230.421,006,525-3.94-1.81%
1 Year212.09261.73167.42218.101,073,0981.870.88%
3 Years243.41285.61165.75221.001,018,137-29.45-12.10%
5 Years140.32285.6181.79192.121,108,37873.6452.48%

IQVIA Description

IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Your Recent History

Delayed Upgrade Clock